Group comparison | p value | Summary | AUC | Sensitivity (%) | Specificity (%) |
---|---|---|---|---|---|
GBC stage I and II vs Healthy | 0.0177 | * | 0.6545 | 25 | 92.68 |
GBC stage IIIA vs Healthy | 0.0155 | * | 0.7395 | 18.18 | 82.93 |
GBC stage IIIB vs Healthy | 0.0789 | ns | 0.7561 | 33.33 | 87.8 |
GBC stage IVB vs Healthy | 0.2635 | ns | 0.5483 | 17.39 | 92.68 |
GBC stage I and II vs GSD | 0.0007 | *** | 0.724 | 41.67 | 95.83 |
GBC stage IIIA vs GSD | 0.0009 | *** | 0.8011 | 45.45 | 91.67 |
GBC stage IIIB vs GSD | 0.1043 | ns | 0.7153 | 33.33 | 91.67 |
GBC stage IVB vs GSD | 0.0419 | * | 0.5951 | 17.39 | 91.67 |
GBC Early stage vs All controls | 0.0005 | *** | 0.6919 | 41.67 | 89.89 |
GBC Advance stage vs All controls | 0.0206 | * | 0.5822 | 15.00 | 89.89 |
LN negative vs All controls | < 0.0001 | *** | 0.7306 | 30.43 | 89.89 |
LN positive vs All controls | 0.2102 | ns | 0.5099 | 13.79 | 89.89 |
All cases vs All controls | 0.0037 | ** | 0.6075 | 15.38 | 95.51 |